FLVCR2 and parasitic infectious disease: As an example, targeting the malarial CCT complex with the antihistamine clemastine could be a new therapeutic approach for this parasitic disease (Lu et al., 2020), and CCT in T cells also promotes an immune response against helminths (Oftedal et al., 2021).